Company PCL, Inc.

Stocks

A241820

KR7241820000

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 2025-03-21			5-day change	1st Jan Change
6,040.00 ^KRW	-1.63%		-.--%	-

24-12-29	Yeom Ju-hwan agreed to acquire 36.90% stake in mCureX Therapeutics, Inc. from PCL, Inc. for KRW 13.0 billion.	CI
24-08-29	PCL, Inc. announced that it has received KRW 4.004999835 billion in funding	CI

Business description: PCL, Inc.

PCL Inc is a Korea-based company principally engaged in development and manufacture of vitro diagnostic medical device for immunological diagnosis. The Companyâ€™s products include blood bank screening products and quick diagnostic products. And the Company also provides platform services.

Number of employees: 31

Sales by Activity: PCL, Inc.

Fiscal Period: December	2020 (KRW)	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)
Vitro Diagnostics-Related Business	53.68B	46.15B	37.22B	8.43B	1.25B

See all business segments

Geographical breakdown of sales: PCL, Inc.

Fiscal Period: December	2020 (KRW)	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)
South Korea	3.91B	599M	28.13B	2.92B	1.17B
Other	-	-	-	138M	34.09M
Asia	-	-	-	3.87B	19.75M
Europe	-	-	-	1.48B	-
Overseas	49.77B	45.55B	9.08B	-	-

See all geographic segments

Executive Committee: PCL, Inc.

Manager	Title	Age	Since
So-Yeon Kim CEO	Chief Executive Officer	55	-
Seong-Woo Lee SAM	Sales & Marketing	42	2024-03-27
Mu-Yong So AUD	Comptroller/Controller/Auditor	53	2024-03-27
Won-Hee Jang AUD	Comptroller/Controller/Auditor	53	2025-03-30
Seung-Ki Hong AUD	Comptroller/Controller/Auditor	72	-

See PCL, INC. governance

Composition of the Board of Directors: PCL, Inc.

Director	Title	Age	Since
So-Yeon Kim BRD	Director/Board Member	55	-
Chul-Joon Kim BRD	Director/Board Member	73	-
Mu-Yong So BRD	Director/Board Member	53	2024-03-27
Seong-Woo Lee BRD	Director/Board Member	42	2024-03-27
Dae-Yeol Kim BRD	Director/Board Member	49	2023-03-30

Composition of the Board of Directors

Shareholders: PCL, Inc.

Name	Stocks	%	Valuation
So-Yeon Kim 0.8415 %	497,910	0.8415 %	105 193 ₩
OLIX PHARMACEUTICALS, INC 0.2348 %	138,962	0.2348 %	29 359 ₩
In-gyu Kim 0.0191 %	11,284	0.0191 %	2 384 ₩
Ji-won Lee 0.004958 %	2,934	0.004958 %	620 ₩
Seung-hyun Lee 0.004958 %	2,934	0.004958 %	620 ₩

List of PCL, INC. shareholders

Company details: PCL, Inc.

PCL, Inc.

99 Digital-ro 9-gil

08510, Seoul

http://www.pclchip.com

Bio Diagnostics & Testing

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PCL, INC.	-1.63%	-.--%	-.--%	-87.33%	10.84M
VERACYTE, INC.	+1.91%	+5.44%	+119.07%	+134.98%	4.78B
ADAPTIVE BIOTECHNOLOGIES CORPORATION	+4.29%	+15.67%	+99.91%	+233.38%	3.58B
BGI GENOMICS CO., LTD.	+5.11%	+3.45%	-26.18%	-38.57%	2.08B
IOVANCE BIOTHERAPEUTICS, INC.	-4.57%	-6.59%	+128.16%	-43.61%	1.77B
CAREDX, INC.	+2.63%	+7.81%	+55.17%	+244.12%	1.51B
MARAVAI LIFESCIENCES HOLDINGS, INC.	-1.44%	+6.77%	+145.02%	-50.52%	907M
SEEGENE, INC.	-3.37%	+6.49%	-12.37%	+39.66%	854M
CURIOX BIOSYSTEMS CO., LTD	-3.83%	+1.31%	+12.59%	-	516M
HANGZHOU ALLTEST BIOTECH CO., LTD.	+3.53%	-0.02%	-36.78%	-18.54%	484M
Average	+0.26%	+3.85%	+48.46%	+45.95%	1.65B
Weighted average by Cap.	+1.61%	+5.86%	+78.34%	+104.50%